HOME >> MEDICINE >> NEWS
New drug to treat enlarged prostate developed at UCL

Millions of men stand to benefit from a discovery by UCL scientists that could provide a breakthrough in the treatment of enlargement of the prostate (BPH). The UCL team has developed a new drug, Rho-kinase inhibitor that, in preliminary tests, has been found to treat the condition by both relaxing the prostate and stopping the growth of cells within it. Their findings are set out in the current issue of the Journal of Urology.

BPH affects approximately 85% of men over the age of 50 and causes frequent urination and irritation due to the obstruction of urine flow. The drugs currently available for treatment of BPH aim to either relax the prostrate or to reduce its size as two separate actions, and also have undesired hormonal effects. These effects, along with the need to take two separate treatments, often lead to problems of patient compliance. The discovery by the UCL scientists is novel in that this new drug can both relax the prostate and stop it from growing, with virtually no hormonal side effects.

Dr Selim Cellek, who led the investigation as a collaborative work between UCL's Wolfson Institute for Biomedical Research and its Institute of Urology and Nephrology, said: "We are very excited by this discovery, as it is a medical breakthrough which represents a major advance in treating a condition that affects such a large proportion of the population. We are still at the development stages and more research will be required before the new treatment becomes available. The next step will be to develop links with investors interested in developing this drug for the treatment of BPH.

"Research has shown that this type of compound can also be used to treat erectile dysfunction (impotence). The future for this line of research is therefore promising since men with an enlarged prostate often suffer from impotence. "

Malcolm Grant, UCL Provost, said: "The conversion of scientific results into new medicines is one of the main aims of th
'"/>

Contact: Dominique Fourniol
d.fourniol@ucl.ac.uk
44-207-679-9728
University College London
27-Nov-2003


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. Hormonal treatment improves survival in high-risk prostate cancer patients
3. Chronic pain treatments more effective when taken together, new study shows
4. Brain activity prior to treatment flags vulnerability to antidepressant side effects
5. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
6. OHSU scientists test medication to treat involuntary weight loss
7. Cultural and social factors influence prostate cancer treatment
8. Research offers hope of new treatments for liver damage
9. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
10. Risky surgery not always necessary to treat cervical disease
11. Stanford patient is first to test new treatment for peripheral arterial disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New drug treat enlarged prostate developed UCL

(Date:7/2/2015)... ... July 02, 2015 , ... The ... Gelatin Capsule manufacturers. The report is a valuable source of guidance and direction ... global and Chinese market for the Gelatin Capsule industry including capacity, production, production ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Dr. Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, which ...
(Date:7/2/2015)... ... 02, 2015 , ... Today, East Liverpool City Hospital announced Pam Akin, RN, ... City Hospital (ELCH). Pam is currently the Chief Nursing Officer at ELCH and will ... holds a master’s degree in health care administration as well as nursing. She has ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... introduced CoolSculpting Plus, an advanced approach to body contouring. CoolSculpting Plus ... 44%. , About the basic CoolSculpting procedure:, The CoolSculpting procedure is ...
(Date:7/2/2015)... ... July 02, 2015 , ... Cs &A, the leader ... announced the release and publication of their newest offering to complement the existing ... Newsletter. , Designed in support of coverage for the full spectrum of ...
Breaking Medicine News(10 mins):Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 2Health News:East Liverpool City Hospital Announces New Surgical Center Leadership 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 2Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 3Health News:Fort Myers Plastic Surgeon Introduces a New and Improved Body Contouring Procedure - CoolSculpting Plus™ 4Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4
(Date:7/2/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/nlfg34/cancer ) ... Technology, Imaging and by Application - Forecast to 2020" report ... expected to reach $13.1 Billion in 2020 from an estimated $7.1 ... The market is dominated by North America , ... , and Rest of the World (RoW). The cancer diagnostics market ...
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... , June 25, 2015 ... has announced the addition of the ... Immunodiagnostics: Global Challenges, Emerging Technologies, Competitive Landscape" ... 2015 New Frontiers in Clinical Chemistry and ... is a new seven-country strategic analysis of ...
Breaking Medicine Technology:Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
Cached News: